Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies

Clinical trial NCT02315118 · UNKNOWN

Trial details

NCT number: NCT02315118
Sponsor: National University Hospital, Singapore
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-Cell Chronic Lymphocytic Leukemia Non-Hodgkin's Lymphoma

Start date: 2014-12-01
Primary completion: 2017-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.